• linkedin
  • Increase Font
  • Sharebar

    What Home DNA Tests Really Tell Us

    23andMe recently gained FDA approval, but will it actually help keep people healthier?


    Although the 23andMe tests gives percentages of increased risk in its reports, there are serious limitations to what the tests can tell someone about their disease risk. “Even if you test negative for all known [disease] genes, your risk for that disease may still be increased based on your family history,” said Mary Freivogel, President of the National Society of Genetic Counselors told Stat. “A negative 23andMe test might provide false assurance.” 

    “A major issue, and one that is not new, is most providers have very basic understanding of how to incorporate genomic information into the care of their patients,” Hulick said. “While we cannot make everyone a genomics expert, we can leverage tools within the electronic medical record to help facilitate incorporation of genomic information into the care of patients. This is the approach NorthShore is taking and is a large part of the Center for Personalized Medicine’s efforts to bring genomics to our frontline physicians and health providers.”

    Related article: Rite Aid First offering genetic testing

    23andMe offered direct-to-consumer reports on disease risk in the past, but the FDA stopped it in 2013, saying that the company had to prove its tests were accurate. Now, the FDA has created what it is calling special controls that allow the company, and any others that want to enter this field, to meet its requirements.

    Other companies offer GHR tests through physicians’ offices and genetic counselors. A few companies now offer pharmacogenetic testing for individuals, done in community pharmacies. After test results come in, the pharmacist goes over the information with that individual to evaluate how genetic factors affect any of the drugs they take.

    The FDA has approved the use of GHR for diseases and conditions that include Parkinson’s, late-onset Alzheimer’s, celiac, alpha-1 antityprsin deficiency, factor XI deficiency, and Gaucher disease type1.

    The 23andMe GHR test costs $199, which includes a report on ethnic ancestry, inherited traits like hair color, and the presence of genes for inherited diseases such as cystic fibrosis and sickle cell anemia. 

    Valerie DeBenedette
    Valerie DeBenedette is Managing Editor of Drug Topics.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available